Go Back
Elm Street Ventures
Elm Street Ventures, based in New Haven, Connecticut, is a venture fund founded in 2006. They focus on Seed to Series D stages, with a portfolio including companies like Cybrexa Therapeutics and Device42. Elm Street Ventures specializes in BioTech, Pharmaceuticals, Healthcare, Apps, Big Data & Analytics, Information Technology, and Software sectors. The fund, led by partner Robert Bettigole, has made 24 investments and has seen 7 successful exits. Elm Street Ventures' primary strategy involves creating and operating life sciences companies based on intellectual property developed at Yale University. For more information, visit their website at www.elmvc.com.
About
About
About
Bio
ESVC principal strategy is to create and initially operate life sciences companies founded on intellectual property developed at Yale
Location
New Haven, Connecticut
Stage
Seed, Series A, Series B, Series C, Series D
Partner name
Robert Bettigole
Bio
ESVC principal strategy is to create and initially operate life sciences companies founded on intellectual property developed at Yale
Location
New Haven, Connecticut
Stage
Seed, Series A, Series B, Series C, Series D
Partner name
Robert Bettigole
Fund
Fund
Fund
Fund Focus
BioTech, Pharmaceuticals, Healthcare, Apps, Big Data & Analytics, Information Technology, Software
Number of investments
24
Number of exits
7
Fund Type
Venture Fund
Portfolio Companies
Cybrexa Therapeutics, Device42
Elm Street Ventures
Elm Street Ventures, based in New Haven, Connecticut, is a venture fund founded in 2006. They focus on Seed to Series D stages, with a portfolio including companies like Cybrexa Therapeutics and Device42. Elm Street Ventures specializes in BioTech, Pharmaceuticals, Healthcare, Apps, Big Data & Analytics, Information Technology, and Software sectors. The fund, led by partner Robert Bettigole, has made 24 investments and has seen 7 successful exits. Elm Street Ventures' primary strategy involves creating and operating life sciences companies based on intellectual property developed at Yale University. For more information, visit their website at www.elmvc.com.
About
Bio
ESVC principal strategy is to create and initially operate life sciences companies founded on intellectual property developed at Yale
Location
New Haven, Connecticut
Stage
Seed, Series A, Series B, Series C, Series D
Partner name
Robert Bettigole
Fund
Fund Focus
BioTech, Pharmaceuticals, Healthcare, Apps, Big Data & Analytics, Information Technology, Software
Number of investments
24
Number of exits
7
Fund Type
Venture Fund
Portfolio Companies
Cybrexa Therapeutics, Device42